vs

Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Robin Energy Ltd. (RBNE). Click either name above to swap in a different company.

Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $3.6M, roughly 1.1× Robin Energy Ltd.).

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

NextEra Energy, Inc. is an American energy company that is the world's largest electric utility holding company by market capitalization, with a valuation of over $170 billion as of Oct 2024. NextEra Energy had revenues of $24.8 billion and 16,700 employees throughout the US and Canada in 2024. It has a current generating capacity of 73 gigawatts. Its subsidiaries include Florida Power & Light (FPL), NextEra Energy Resources (NEER), XPLR Energy Partners, and NextEra Energy Services.

IRD vs RBNE — Head-to-Head

Bigger by revenue
IRD
IRD
1.1× larger
IRD
$3.9M
$3.6M
RBNE

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
IRD
IRD
RBNE
RBNE
Revenue
$3.9M
$3.6M
Net Profit
Gross Margin
Operating Margin
12.1%
Net Margin
Revenue YoY
-10.2%
Net Profit YoY
53.0%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRD
IRD
RBNE
RBNE
Q4 25
$3.9M
Q3 25
$3.1M
Q2 25
$2.9M
$3.6M
Q1 25
$4.4M
Q4 24
$4.3M
Q3 24
$3.9M
Q2 24
$1.1M
Q1 24
$1.7M
Net Profit
IRD
IRD
RBNE
RBNE
Q4 25
Q3 25
$-17.5M
Q2 25
$-7.4M
Q1 25
$-8.2M
Q4 24
Q3 24
$-7.5M
Q2 24
$-7.8M
Q1 24
$-7.1M
Operating Margin
IRD
IRD
RBNE
RBNE
Q4 25
Q3 25
-269.9%
Q2 25
-309.0%
12.1%
Q1 25
-227.2%
Q4 24
Q3 24
-207.1%
Q2 24
-748.9%
Q1 24
-450.5%
Net Margin
IRD
IRD
RBNE
RBNE
Q4 25
Q3 25
-566.9%
Q2 25
-257.5%
Q1 25
-187.5%
Q4 24
Q3 24
-194.6%
Q2 24
-698.3%
Q1 24
-415.3%
EPS (diluted)
IRD
IRD
RBNE
RBNE
Q4 25
Q3 25
$-0.25
Q2 25
$-0.12
Q1 25
$-0.24
Q4 24
Q3 24
$-0.29
Q2 24
$-0.30
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRD
IRD
RBNE
RBNE
Cash + ST InvestmentsLiquidity on hand
$45.1M
$39.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$15.3M
$20.5M
Total Assets
$50.2M
$48.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRD
IRD
RBNE
RBNE
Q4 25
$45.1M
Q3 25
$30.8M
Q2 25
$32.4M
$39.4M
Q1 25
$41.8M
Q4 24
$30.3M
Q3 24
$36.6M
Q2 24
$41.4M
Q1 24
$47.2M
Stockholders' Equity
IRD
IRD
RBNE
RBNE
Q4 25
$15.3M
Q3 25
$6.0M
Q2 25
$17.5M
$20.5M
Q1 25
$5.1M
Q4 24
$6.7M
Q3 24
$34.3M
Q2 24
$40.6M
Q1 24
$46.1M
Total Assets
IRD
IRD
RBNE
RBNE
Q4 25
$50.2M
Q3 25
$36.1M
Q2 25
$38.7M
$48.6M
Q1 25
$48.2M
Q4 24
$36.9M
Q3 24
$40.4M
Q2 24
$44.8M
Q1 24
$51.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRD
IRD
RBNE
RBNE
Operating Cash FlowLast quarter
$-35.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRD
IRD
RBNE
RBNE
Q4 25
$-35.3M
Q3 25
$-6.2M
Q2 25
$-10.3M
Q1 25
$-9.0M
Q4 24
$-25.6M
Q3 24
$-5.1M
Q2 24
$-7.3M
Q1 24
$-5.7M
Capex Intensity
IRD
IRD
RBNE
RBNE
Q4 25
Q3 25
Q2 25
0.0%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons